MAI Capital Management’s Filana Therapeutics FLNA Stock Holding History

MAI Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.54K	Hold	1,500	–	–	﹤0.01%	3841
2025 Q4	$2.97K	Hold	1,500	–	–	﹤0.01%	3310
2025 Q3	$4.37K	Hold	1,500	–	–	﹤0.01%	3070
2025 Q2	$2.71K	Hold	1,500	–	–	﹤0.01%	3312
2025 Q1	$2.25K	Sell	1,500 -1,092	-42%	-$2.76K	﹤0.01%	2955
2024 Q4	$6.12K	Buy	+2,592	New	+$45.5K	﹤0.01%	2704
2023 Q1	–	Sell	-6,782	Closed	-$200K	–	1094
2022 Q4	$200K	Buy	+6,782	New	+$244K	﹤0.01%	910

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

MAI Capital Management's FLNA Position: Q1 2026 in Review

MAI Capital Management held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 1,500 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

MAI Capital Management first reported a position in FLNA in Q4 2022 and has held it in 7 quarters since. The position peaked at $200K in Q4 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

MAI Capital Management held 1,500 shares of Filana Therapeutics worth $2.54K as of Q1 2026.
MAI Capital Management left its Filana Therapeutics share count unchanged in Q1 2026.
Filana Therapeutics made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3841 holding.
MAI Capital Management first reported a position in Filana Therapeutics in Q4 2022 and has held it in 7 quarters since.
MAI Capital Management's Filana Therapeutics position peaked at $200K in Q4 2022.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.